Our study revealed that increased expression of KDM1A can potentiate hepatic steatosis and inflammation by increasing chromatin accessibility in the genomic regions related to the pathogenesis of NAFLD, further indicating that dynamic changes in chromosomal structure under metabolic stress can lead to the development of NAFLD. This evidence concerns the gene KDM1A and metabolic dysfunction-associated steatotic liver disease.